
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
N6‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
Shenghua Dong, Yutong Wu, Yadi Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 538-559
Open Access | Times Cited: 34
Shenghua Dong, Yutong Wu, Yadi Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 538-559
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 161
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 161
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 149
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 149
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 77
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 77
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Roles and implications of mRNA N6‐methyladenosine in cancer
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 20
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 20
Regulations of m6A and other RNA modifications and their roles in cancer
Xinhui Chen, Kunxiong Guo, Jing Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 622-648
Closed Access | Times Cited: 5
Xinhui Chen, Kunxiong Guo, Jing Li, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 622-648
Closed Access | Times Cited: 5
Integrative machine learning model of RNA modifications predict prognosis and treatment response in patients with breast cancer
Tao Wang, Shu Wang, Zhuolin Li, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Tao Wang, Shu Wang, Zhuolin Li, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
Leping Liu, Lu Lu, Qiangqiang Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 36
Leping Liu, Lu Lu, Qiangqiang Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 36
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing
Tongxuan Wen, Tong Li, Yeqiu Xu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Tongxuan Wen, Tong Li, Yeqiu Xu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Crosstalk between histone/DNA modifications and RNA N6-methyladenosine modification
Yushuai Wang, He Huang, Jianjun Chen, et al.
Current Opinion in Genetics & Development (2024) Vol. 86, pp. 102205-102205
Open Access | Times Cited: 3
Yushuai Wang, He Huang, Jianjun Chen, et al.
Current Opinion in Genetics & Development (2024) Vol. 86, pp. 102205-102205
Open Access | Times Cited: 3
Crosstalk between m6A regulators and mRNA during cancer progression
Xiaodong Niu, Yuan Yang, Yanming Ren, et al.
Oncogene (2022) Vol. 41, Iss. 39, pp. 4407-4419
Closed Access | Times Cited: 17
Xiaodong Niu, Yuan Yang, Yanming Ren, et al.
Oncogene (2022) Vol. 41, Iss. 39, pp. 4407-4419
Closed Access | Times Cited: 17
Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m6A RNA methylation in ocular melanoma
Ai Zhuang, Xiang Gu, Tongxin Ge, et al.
Cancer Communications (2023) Vol. 43, Iss. 11, pp. 1185-1206
Open Access | Times Cited: 9
Ai Zhuang, Xiang Gu, Tongxin Ge, et al.
Cancer Communications (2023) Vol. 43, Iss. 11, pp. 1185-1206
Open Access | Times Cited: 9
An Interplay between Epigenetics and Translation in Oocyte Maturation and Embryo Development: Assisted Reproduction Perspective
Michal Dvoran, Lucie Němcová, Jaroslav Kalous
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1689-1689
Open Access | Times Cited: 14
Michal Dvoran, Lucie Němcová, Jaroslav Kalous
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1689-1689
Open Access | Times Cited: 14
Novel insight into the functions of N6‑methyladenosine modified lncRNAs in cancers (Review)
Ying‐Jie He, Xuezhi Du, Ming Chen, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 6
Open Access | Times Cited: 14
Ying‐Jie He, Xuezhi Du, Ming Chen, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 6
Open Access | Times Cited: 14
Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing
Zhen Zhang, Chuanhua Cao, Chunli Zhou, et al.
Translational Oncology (2023) Vol. 36, pp. 101741-101741
Open Access | Times Cited: 8
Zhen Zhang, Chuanhua Cao, Chunli Zhou, et al.
Translational Oncology (2023) Vol. 36, pp. 101741-101741
Open Access | Times Cited: 8
Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
Liang Zhao, Junchen Guo, Shasha Xu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Liang Zhao, Junchen Guo, Shasha Xu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Emerging role of m6A methylation modification in ovarian cancer
Linlin Chang, Xiaqing Xu, Xueling Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Linlin Chang, Xiaqing Xu, Xueling Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15
The Key Role of RNA Modification in Breast Cancer
Yang Liu, Tong Zhu, Yi Jiang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Yang Liu, Tong Zhu, Yi Jiang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Global burden of cancers attributable to tobacco smoking, 1990–2019: an ecological study
Rajesh Sharma, Bijoy Rakshit
The EPMA Journal (2022) Vol. 14, Iss. 1, pp. 167-182
Open Access | Times Cited: 8
Rajesh Sharma, Bijoy Rakshit
The EPMA Journal (2022) Vol. 14, Iss. 1, pp. 167-182
Open Access | Times Cited: 8
Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4
The Importance of the Epi-Transcriptome in Translation Fidelity
Charlène Valadon, Olivier Namy
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 51-51
Open Access | Times Cited: 11
Charlène Valadon, Olivier Namy
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 51-51
Open Access | Times Cited: 11
Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer
Ziying Zhang, Peng Chen, Jingping Yun
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Ziying Zhang, Peng Chen, Jingping Yun
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
RNA Epigenetics in Chronic Lung Diseases
Xiaorui Wang, Zhihou Guo, Furong Yan
Genes (2022) Vol. 13, Iss. 12, pp. 2381-2381
Open Access | Times Cited: 5
Xiaorui Wang, Zhihou Guo, Furong Yan
Genes (2022) Vol. 13, Iss. 12, pp. 2381-2381
Open Access | Times Cited: 5
N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis
Hengyou Weng, Huilin Huang, Jianjun Chen
Advances in experimental medicine and biology (2023), pp. 105-123
Closed Access | Times Cited: 2
Hengyou Weng, Huilin Huang, Jianjun Chen
Advances in experimental medicine and biology (2023), pp. 105-123
Closed Access | Times Cited: 2